ИΛKΛDΛI on Nostr: New paper from Italy, Istituto Superiore di Sanità, the Italian equivalent to NIH, ...
New paper from Italy, Istituto Superiore di Sanità, the Italian equivalent to NIH, have just a published a risk-benefit analysis of the mRNA vaccines.
Conclusion: The scientific community needs to be aware and discuss whether the use of the current genetic COVID-19 vaccines, which was justified at the time of earlier deadly coronavirus variants, should still be encouraged at the time of Omicron variants.
Pivot is coming.
https://www.mdpi.com/2076-0817/12/2/233#B81-pathogens-12-00233
Conclusion: The scientific community needs to be aware and discuss whether the use of the current genetic COVID-19 vaccines, which was justified at the time of earlier deadly coronavirus variants, should still be encouraged at the time of Omicron variants.
Pivot is coming.
https://www.mdpi.com/2076-0817/12/2/233#B81-pathogens-12-00233